Protecting Study Continuity Through Local Sourcing in China
The Challenge A leading BAP Pharma client required urgent local sourcing in China for a decentralised clinical study in immunology. The immediate need was to secure supply of Skyrizi® 360 mg and 600 mg within an accelerated one-month timeline, without disrupting patient treatment or wider study continuity.Operating in a complex local market under significant time […]
Accelerating Phase III Trial Restart in Turkey: End-to-end recovery delivered in under 7 days across 17 clinical sites
The Challenge A critical Phase III cardiovascular trial restart was placed at immediate risk when a previous supplier failed to deliver six essential standard-of-care (AxMP) medications across 17 clinical sites in Turkey. With no room for delay, the consequences were significant: missed dosing windows, inactive sites, and further disruption to study timelines and costs. The […]
Agile Approach to Comparator Sourcing
The Sponsor was initially unsure of their enrolment and subsequently experienced rapid patient enrolment, which led to the need for increased quantities of materials and an unexpected change in their packaging schedule. Their on-going forecast identified a risk in both the timely fulfilment and expedited delivery to meet their revised patient recruitment timelines.
Revolutionizing Clinical Trial Supply: How BAP Pharma’s Agile Approach Redefines Comparator Sourcing
Clinical trials are the backbone of medical innovation, but they require precision, efficiency, and adaptability to succeed. Traditional comparator sourcing and clinical labelling strategies often come with rigid timelines, financial strain, and inefficiencies that can hinder progress. At BAP Pharma, we offer a smarter approach—one that enhances agility, minimizes risk, and optimizes costs. The Challenge: […]
Eliminating Delays to Clinical Studies
BAP Pharma received an urgent request from a new client in October 2021, for an order of medical devices. These needed to be sourced from a specific supplier for use in an ongoing clinical study.
Circumventing manufacturing issues due to Covid-19
BAP was able to source the full quantity of vaccines, with full documentation, in just 2 weeks, ensuring continuity of supply for the client’s trial.
Policy Change Management with Manufacturer
BAP differentiated itself from its competitors by being the only company able to influence the manufacturer to change its policy.
Meeting tight deadlines for a client
BAP Pharma provided great flexibility and used our new BAP GmbH site to leverage deals that would otherwise not be available.